secwatch.observer — SEC 8-K summary
======================================

Issuer:     Core Laboratories Inc. /DE/ (CLB)
CIK:        0001958086
Form:       8-K
Filed at:   2025-07-23T23:59:59+00:00
Accession:  0000950170-25-097897
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.02, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Core Lab Q2 rev $130.2M (+5% seq, flat YoY); ex-items EPS $0.19; free cash flow $10.4M
--------------------------------------------------------------------------------

- Q2 revenue $130.2M (+5% sequentially, flat YoY); GAAP EPS $0.22; ex-items EPS $0.19 (-14% YoY, +33% sequentially).
- Ex-items operating income $14.5M, margins 11% (+160 bps seq); incremental margins 41%.
- Free cash flow $10.4M (+160% seq); net debt reduced $9.1M; leverage ratio improved to 1.27x.
- Company repurchased 237,632 shares for $2.7M in Q2.
- Credit facility amended: commitments raised to $150M from $135M, maturity extended to July 2029, $50M accordion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958086/000095017025097897/0000950170-25-097897-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958086/000095017025097897/clb-20250722.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-097897

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer